Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin

Chemical Biology and Drug Design

Volumn 72, Issue 4, 2008, Pages 290-296

  Seedher, Neelam ^a   Kanojia, Mamta ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Binding; Fluorescence; Gliclazide; Human serum albumin; Repaglinide

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; ANTIDIABETIC AGENT; GLICLAZIDE; HUMAN SERUM ALBUMIN; REPAGLINIDE; TRYPTOPHAN; TYROSINE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONFORMATIONAL TRANSITION; DRUG PROTEIN BINDING; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; PARTICLE SIZE; PRIORITY JOURNAL;

ANILINO NAPHTHALENESULFONATES; BINDING SITES; CARBAMATES; FLUORESCENT DYES; GLICLAZIDE; HUMANS; HYDROPHOBICITY; HYPOGLYCEMIC AGENTS; MODELS, BIOLOGICAL; PIPERIDINES; PROTEIN BINDING; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS; TRYPTOPHAN;

EID: 52649098026     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00704.x     Document Type: Article

References (31)

1. Kragh-Hansen U., Chuang V.T.G., Otagiri M. (2002) Practical aspects of the ligand binding and enzymatic properties of human serum albumin. Biol Pharm Bull 25 : 695 704.
2. Seedher N., Bhatia S. (2005) Mechanism of interaction of non-steriodal anti-inflammatory drugs meloxicam and nimesulide with serum albumin. J Pharm Biomed Anal 39 : 257 262.
3. Seedher N., Bhatia S. (2006) Reversible binding of celecoxib and valdecoxib with human serum albumin using fluorescence spectroscopic technique. Pharmacol Res 54 : 77 84.
4. Hsu P., Ma J.K.H., Luzzi L.A. (1974) Interactions of sulfonylureas with plasma proteins. J Pharm Sci 63 : 570 573.
5. Crooks M.J., Brown K.F. (1973) Binding of sulfonylureas to serum albumin. J Pharm Sci 62 : 1904 1907.
6. Izumi T. (1997) Determination of protein binding of troglitazone sterioisomers by fluorimetric titration. Biopharm Drug Dispos 18 : 241 257.
7. Zhong W., Wang Y., Yu J.S., Liang Y., Ni K., Tu S. (2004) The interaction of human serum albumin with a novel antidiabetic agent-SU-118. J Pharm Sci 93 : 1039 1046.
8. Koyama H., Sugioka N., Uno A., Moris S., Nakajima K. (1997) Effects of glycosylation of hypoglycemic drug binding to serum albumin. Biopharm Drug Dispos 18 : 791 801.
9. Plum A., Muller L.K., Jansen J.A. (2000) The effects of selected drugs on the in vitro protein binding of repaglinide in human plasma. Methods Find Exp Clin Pharmacol 22 : 139 143.
10. Winters C.S., Shields L., Timmins P., York P. (1994) Solid state properties and crystal structure of gliclazide. J Pharm Sci 33 : 300 304.
11. Mandic Z., Gabelica V. (2006) Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal 41 : 866 871.
12. Rahman M.H., Maruyama T., Okada T., Yamasaki K., Otagiri M. (1993) Study of interaction of carprofen and its enantiomers with human serum albumin-I. Mechanism of binding studied by dialysis and spectroscopic methods. Biochem Pharmacol 46 : 1721 1731.
13. Weber G., Young L.B. (1964) Fragmentation of bovine serum albumin by pepsin. I. The origin of the acid expansion of the albumin molecule. J Biol Chem 239 : 1415 1423.
14. 1-acid glycoprotein and human serum albumin. Int J Pharm 59 : 137 143.
15. Ward L.D. (1985) Measurement of ligand binding to proteins by fluorescence spectroscopy. Methods Enzymol 117 : 400 414.
16. Martin B.K. (1965) Potential effect of the plasma proteins on drug distribution. Nature 207 : 274 276.
17. Pang Y.H., Yang L.L., Shuang S.M., Dong C., Thompson M. (2005) Interaction of human serum albumin with bendroflumethiazide studied by fluorescence spectroscopy. J Photochem Photobiol B 80 : 139 144.
18. Liu J., Tian J., Tian X., Hu Z., Chen X. (2004) Interaction of isofraxidin with human serum albumin. Bioorg Med Chem 12 : 469 474.
19. Sulkowska A., Bojko B., Rownicka J., Sulkowski W.W. (2006) Paracetamol and cytarabine binding competition in high affinity binding sites of transporting protein. J Mol Struc 792 : 249 256.
20. Jun H.W., Ruenitz P.C. (1978) Interaction of tricyclic antipsychotic and antidepressant drugs with 1-anilino-8-naphthalenesulfonic acid. J Pharm Sci 67 : 861 863.
21. Thumser A.E.A., Buckland A.G., Wilton D.C. (1998) Monoacylglycerol binding to human serum albumin: evidence that monooleyglycerol binds at the dansylsarcosine site. J Lipid Res 39 : 1033 1038.
22. Sudlow G., Birkett D., Wade D. (1975) The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11 : 824 832.
23. Nerli B., Romanini D., Pico G. (1997) Structural specificity requirements in the binding of beta lactam antibiotics to human serum albumin. Chem Biol Interact 104 : 179 202.
24. Kasai S., Horie T., Mizuma T., Awazu S. (1987) Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin. J Pharm Sci 76 : 387 392.
25. Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K. (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng 12 : 439 446.
26. Wanwimolruk S., Birkett D.J., Brooks P.M. (1983) Structural requirements for drug binding to site II on human serum albumin. Mol Pharmacol 24 : 458 463.
27. Watanabe H., Tanase S., Nakajou K., Maruyama T., Kragh-Hansen U., Otagiri M. (2000) Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem J 349 : 813 819.
28. Eftink M.R., Ghiron C.A. (1981) Fluorescence quenching studies with proteins. Anal Biochem 114 : 199 227.
29. Lehrer S.S. (1971) Solute perturbation of fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry 10 : 3254 3263.
30. Midoux P., Wahl P., Auchet J., Monsigny M. (1984) Fluorescence quenching of tryptophan by trifluoroacetamide. Biochim Biophys Acta 801 : 16 25.
31. Silva D., Cortez C.M., Louro S.R.W. (2004) Chlorpromazine interactions to sera albumins A study by the quenching of fluorescence. Spectrochimica Acta A 60 : 1215 1223.